Ocrelizumab monoclonal antibody drug. Targets CD20 on B-cells and is used in the treatment multiple sclerosis. Generic name and stylized antibody.

---

Size: 9000px × 4730px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, -lymphocyte, anti-cd20, antibody, biological, biosimilar, biotech, biotechnology, cd-20, cd20, disease, drug, immunoglobulin, immunology, immunosuppression, immunosuppressive, infusion, injection, inn, mab, monoclonal, multiple, nomenclature, ocrelizumab, peptide, protein, sclerosis